Results 201 to 210 of about 30,599,032 (364)

PYCR1 inhibition in bone marrow stromal cells enhances bortezomib sensitivity in multiple myeloma cells by altering their metabolism

Molecular Oncology, EarlyView.
This study investigated how PYCR1 inhibition in bone marrow stromal cells (BMSCs) indirectly affects multiple myeloma (MM) cell metabolism and viability. Culturing MM cells in conditioned medium from PYCR1‐silenced BMSCs impaired oxidative phosphorylation and increased sensitivity to bortezomib.
Inge Oudaert, Lauren van den Broecke, Osman Aksoy, Judith Lind, Sonia Vallet, Arne Van der Vreken, Gamze Ates, Ann Massie, Ken Maes, Kim De Veirman, Elke De Bruyne, Karin Vanderkerken, Klaus Podar, Eline Menu   +13 more
wiley   +1 more source

Data mining in Raman imaging in a cellular biological system. [PDF]

Comput Struct Biotechnol J, 2020
Liu YJ, Kyne M, Wang C, Yu XY.
europepmc   +1 more source

Deferoxamine-Modified Hybrid Materials for Direct Chelation of Fe(III) Ions from Aqueous Solutions and Indication of the Competitiveness of In Vitro Complexing toward a Biological System. [PDF]

ACS Omega, 2021
Pawlaczyk M, Schroeder G.
europepmc   +1 more source

Combined Biological Effects of N-Bromotaurine Analogs and Ibuprofen. Part II: Influence on a Local Defense System

, 2019
Angelika Peruń, Marta Ciszek‐Lenda, Maria Walczewska, Aneta Kiecka, Anna Białecka, Markus Nagl, Waldemar Gottardi, Janusz Marcinkiewicz   +7 more
openalex   +2 more sources

Nutrient dynamics and biological consumption in a large continental shelf system under the influence of both a river plume and coastal upwelling [PDF]

, 2012
Aiqin Han, Minhan Dai, Shuh‐Ji Kao, Jianping Gan, Qing Li, Lifang Wang, Weidong Zhai, Lei Wang   +7 more
openalex   +1 more source

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

Molecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser, Jan Niklas Schäfer, Shraga Nahum Goldberg, Philipp Maximilian Kazmierczak, Moritz Nikolaus Gröper, Philipp Franz Linden, Elif Öcal, Tanja Burkard, Stefanie Corradini, Najib Ben Khaled, Moritz Wildgruber, Max Seidensticker, Jens Ricke, Matthias Stechele, Marianna Alunni‐Fabbroni   +14 more
wiley   +1 more source

Photocatalytic therapy via photoinduced redox imbalance in biological system. [PDF]

Nat Commun
Zhou K, Du L, Ding R, Xu L, Shi S, Wang S, Wang Z, Zhang G, He G, Zhao Z, Tang BZ.   +10 more
europepmc   +1 more source

Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine

Molecular Oncology, EarlyView.
The CDK9 inhibitor AZD4573 downregulates c‐MYC and MCL‐1 to induce death of cytarabine (AraC)‐resistant AML cells. This enhances VEN + AZA‐induced cell death significantly more than any combination of two of the three drugs in AraC‐resistant AML cells.
Shuangshuang Wu, Jianlei Zhao, Aaban Asfar Azmi, Avanti Gupte, Jenna Thibodeau, Shuang Liu, Jinli Yang, Guan Wang, Holly Edwards, Lisa A. Polin, Juiwanna Kushner, Sijana H. Dzinic, Kathryn White, Julie Boerner, Maik Hüttemann, Jay Yang, Yue Wang, Jeffrey W. Taub, Yubin Ge   +18 more
wiley   +1 more source

A Review: Development of a Synthetic Lactoferrin Biological System. [PDF]

Biodes Res
Liu K, Tong Z, Zhang X, Dahmani M, Zhao M, Hu M, Li X, Xue Z.   +7 more
europepmc   +1 more source

Enlightening Gliotoxin Biological System in Agriculturally Relevant Trichoderma spp. [PDF]

Front Microbiol, 2020
Bulgari D, Fiorini L, Gianoncelli A, Bertuzzi M, Gobbi E.   +4 more
europepmc   +1 more source